The Patent Finder

Kos Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Kos Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Kos Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,155,251Breath coordinated inhaler
Formerly held
Term ended
Term ended Mar 4, 2019 · From the USPTO record
Term endedTerm ended Mar 4, 2019From the USPTO record
US 6,090,830Controlled release compositions and methods for the treatment of hyperlipidemia
Formerly held
Term ended
Term ended Jul 20, 2018 · From the USPTO record
Term endedTerm ended Jul 20, 2018From the USPTO record
US 7,074,388Water Stabilized Medicinal Aerosol Formulation
Formerly held
Lapsed on the fee record
Ended Jul 11, 2018 · Low confidence
Lapsed on the fee recordEnded Jul 11, 2018Low confidence
US 6,469,035Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid
Formerly held
Term ended
Term ended Mar 15, 2018 · From the USPTO record
Term endedTerm ended Mar 15, 2018From the USPTO record
US 6,106,606Spherical particles on the basis of metal oxides, method for its manufacture and its utilization
Formerly held
Term ended
Term ended Oct 29, 2017 · From the USPTO record
Term endedTerm ended Oct 29, 2017From the USPTO record
US 6,080,428Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
Formerly held
Term ended
Term ended Jun 27, 2017 · From the USPTO record
Term endedTerm ended Jun 27, 2017From the USPTO record
US 6,129,930Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
Formerly held
Term ended
Term ended Mar 6, 2017 · From the USPTO record
Term endedTerm ended Mar 6, 2017From the USPTO record
US 6,020,305Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors
Formerly held
Term ended
Term ended Aug 6, 2016 · From the USPTO record
Term endedTerm ended Aug 6, 2016From the USPTO record
US 6,596,308Controlled release pharmaceutical composition
Formerly held
Lapsed on the fee record
Ended Jul 22, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 22, 2015From the USPTO record
US 6,524,615Controlled release pharmaceutical composition
Formerly held
Lapsed on the fee record
Ended Feb 25, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 25, 2015From the USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited